Rising Antimicrobial Resistance Poses Critical Threat to Neurocritical Care Patients ~ Leading Neurocritical Care Experts Convened at the highly successful 7th Annual National Conference of the Society of Neurocritical Care of India (SNCC) on September 21-22, 2024, Mumbai to address the pressing need for novel anti-infective treatments in
A total of 5248 patients with COVID19 were admitted between March 2020 to May 2021, of which 1027 were in ICU and 4221 inwards There were 417 patients with Diabetes Mellitus out of 1027 The blood glucose levels of patients were maintained between 140
Adding another leg to our battle against COVID19, the Government of India has introduced, a promising anti-COVID19 drug called 2-deoxy-D-glucose (2-DG). The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of Defence Research and Development Organisation (DRDO),
